HealthEquity, Inc. P/E Ratio 2013–2026
HealthEquity, Inc. reported 34.83 of price-to-earnings ratio for fiscal 2026. That was 65.6% lower than fiscal 2025. Compared with fiscal 2021, the change was -95.0%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2026 | 34.83 | -65.6% |
| FY 2025 | 101.30 | -14.2% |
| FY 2024 | 118.09 | — |
| FY 2023 | — | — |
| FY 2022 | — | — |
| FY 2021 | 696.25 | +511.3% |
| FY 2020 | 113.90 | +113.8% |
| FY 2019 | 53.28 | -19.0% |
| FY 2018 | 65.74 | -37.5% |
| FY 2017 | 105.11 | +36.6% |
| FY 2016 | 76.96 | -22.2% |
| FY 2015 | 98.90 | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
Source: HealthEquity, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HQY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
HealthEquity, Inc. reported 34.83 of price-to-earnings ratio for fiscal 2026. That was 65.6% lower than fiscal 2025. Compared with fiscal 2021, the change was -95.0%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for HealthEquity, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHealthEquity, Inc. — frequently asked questions
What is HealthEquity, Inc.'s price-to-earnings ratio?
HealthEquity, Inc. (HQY) reported price-to-earnings ratio of 34.83 for fiscal year 2026, per its SEC filings.
How has HealthEquity, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2013 and 2026, HQY's price-to-earnings ratio declined at roughly 7.7% per year (compound annual rate), from 98.90 to 34.83.
Where does this data come from?
Figures are computed from HealthEquity, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More HQY financial history
Full HQY fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →